The integration of artificial intelligence (AI) into drug discovery is revolutionizing pharmaceutical research by providing sophisticated tools for understanding and predicting complex biological ...
Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...
Pharmaceutical Technology on MSN
Elevara explores CDK4/6 inhibition for the treatment of rheumatoid arthritis
The new biotech Elevara plans to initiate Phase II testing of its lead candidate ELV001 as an add-on treatment for rheumatoid ...
Serious side effects of metformin are rare. Less serious side effects, like digestive issues and headaches, are common, but these usually go away with time. You can reduce the chances of side effects ...
NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora’s M4 franchise; both programs have potential best-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback